BSEInsider Trading / SAST26 Sept 2026 · 26 Sept 2026, 03:14 pm

Intimation of Closure of Trading window.

Genpharmasec Ltd · 531592

✦ AI Summary

Genpharmasec Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its un-audited financial results for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk2/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Genpharmasec Ltd - 531592 - Closure of Trading Window

Attachments (1)

📄

b512b3a6-d4eb-4936-a2c0-3d622b906201.pdf

pdf

Download →
View document text
GENPHARMASEC LIMITED Date: 26.09.2026 BSE Limited The Compliance Department of Corporate Services, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code: 531592 Subject: Intimation regarding closure of Trading Window. Dear Sir/ Madam, Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading and Disclosure Practices, the Trading Window for dealing in securities of the Company by its Promoters, Members of Promoter Group, Directors, Key Managerial Persons and Designated Persons & their immediate relatives shall remain closed from Thursday, October 01, 2026 till 48 hours after the declaration of Un- audited Financial Results of the Company for the quarter and half year ended on 30‘ September, 2026. Accordingly, all Insiders/Designated Persons & their immediate relatives have been advised not to trade in the Securities of the Company during the aforesaid period of closure of Trading Window. Further, date of meeting of the Board of Directors to consider and approve the Un-Audited Financial Results for the quarter and half year ended on 30‘ September, 2026 will be intimated in due course. This is for your information and records. Thanking you, Yours faithfully, For Genpharmasec Limited Digitally signed by, SOHAN SOHAN CHATURVEB I Date: 2026.09.26 \4 CHATURVEDI 148280 +05'30' Mr. Sohan Chaturvedi Whole time director & CFO DIN- 09629728 104 & 105, 1st Floor, Gundecha Industrial Premises Co-Operative Soc compliance@genpharmasec.com Ltd., Akurli Road, Kandivali (East), Mumbai 400101. info@genpharmasec.com © +91-86555 50242 GP www.genpharmasec.com CIN : L24231MH1992PLC323914